Marta Baviera - Concepedia

Author

Marta Baviera

Mario Negri Institute for Pharmacological Research ORCID

Also Known As

M Baviera, M. Baviera, M. E. Baviera, Marta Baviera, Mauro Tettamanti

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Mario Negri Institute for Pharmacological Research Regione Lombardia Ministero della Salute Istituti di Ricovero e Cura a Carattere Scientifico Icahn School of Medicine at Mount Sinai

About

Marta Baviera is an author at Mario Negri Institute for Pharmacological Research specializing in medicine, public health, and health policy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	1.1K
2	Public Health	11	12	718
3	Social Sciences	5	5	435
4	Nursing	1	1	29
5	Behavioral Sciences	1	1	54

Marta Baviera

Publications

Citations

H-Index

Page 1

	Year	Citations
A Polypill Strategy to Improve Adherence José M. Castellano, Ginés Sanz, José L. Peñalvo, Journal of the American College of Cardiology Non-pharmacological InterventionPreventive MedicineHealth PolicyTreatment And PreventionHealth Promotion	2014	342
Polypill Strategy in Secondary Cardiovascular Prevention José M. Castellano, Stuart Pocock, Deepak L. Bhatt, New England Journal of Medicine	2022	295
Dissociable Contribution of 5-HT1A and 5-HT2A Receptors in the Medial Prefrontal Cortex to Different Aspects of Executive Control such as Impulsivity and Compulsive Perseveration in Rats Mirjana Carli, Marta Baviera, Roberto William Invernizzi, Neuropsychopharmacology Dissociable ContributionNeuropsychologyInhibitory ProcessAffective NeuroscienceImpulsivity	2005	187
The Serotonin 5-HT2A Receptors Antagonist M100907 Prevents Impairment in Attentional Performance by NMDA Receptor Blockade in the Rat Prefrontal Cortex Mirjana Carli, Marta Baviera, Roberto William Invernizzi, Neuropsychopharmacology NeuropsychologySerotonin 5-Ht2a ReceptorsPsychiatryNeurophysiologyMedicine	2004	100
Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data Dianna J. Magliano, Lei Chen, Bendix Carstensen, The Lancet Diabetes & Endocrinology All-cause MortalityEpidemiological TrendDiabetes ManagementDiabetes EpidemiologyHealth Policy	2022	83
The 5‐HT<sub>2A</sub> receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC Ilaria Ceglia, Mirjana Carli, Marta Baviera, Journal of Neurochemistry	2004	78
Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population‐based study Lara Monesi, Marta Baviera, Irene Marzona, Diabetic Medicine	2011	76
Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction Marta Baviera, Stefano Genovese, Pierluca Colacioppo, Cardiovascular Diabetology	2022	76
Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM‐elderly project Alessandro Nobili, Carlotta Franchi, Luca Pasina, Pharmacoepidemiology and Drug Safety	2011	73
Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study Dunya Tomic, Jedidiah I Morton, Lei Chen, The Lancet Diabetes & Endocrinology Diabetes EpidemiologyHealth PolicyDisease Risk AssessmentLongevityGlobal Health	2022	66

Page 1